UNMC_Acronym_Vert_sm_4c
University of Nebraska Medical Center

Category: Vaccine Headlines

Breakthrough Monkeypox Cases Seen Weeks After Second Jynneos Dose

MedPageToday – Most cases of monkeypox post-vaccination occurred within 2 weeks of the first Jynneos dose, a single-center study found, but some breakthrough cases developed weeks after a second dose of the vaccine. Of 90 individuals who tested positive for monkeypox after a single dose of Jynneos at a large monkeypox testing and vaccination site, […]

Oct 6, 2022

At Long Last, Can Malaria Be Eradicated?

New York Times – Two new vaccines may finally turn back an ancient plague. But in unexpected ways, their arrival also complicates the path to ending the disease. A more powerful malaria vaccine, developed by the Oxford team that created the AstraZeneca Covid vaccine, may be just a year or two away. Many experts believe […]

Oct 4, 2022

A Public Health Success Story

NYT – The Covid mass vaccination program in the U.S. began on Dec. 14, 2020, when a nurse at a hospital in Queens, N.Y., received a shot on live television. But more than two months later, a major health clinic based in North Birmingham, Ala. — which focused on lower-income, Black and Latino residents — […]

Oct 4, 2022

Two thirds of U.S. adults don’t plan on getting COVID boosters soon

Reuters – Around two-thirds of adults in the United States do not plan to get updated COVID-19 booster shots soon, according to a survey conducted by the Kaiser Family Foundation (KFF), a health policy nonprofit organization.Only a third of adults polled said they either already received the updated shots or plan to get the booster […]

Oct 3, 2022

Scientists race to test vaccines for Uganda’s Ebola outbreak

Science – A multipronged international effort has begun to pull out all the stops to launch trials of experimental Ebola vaccines in Uganda, which declared an outbreak of the deadly disease on 20 September. According to the most recent World Health Organization (WHO) update, Uganda has had 18 confirmed and 18 suspected cases of Ebola, […]

Sep 30, 2022

Two COVID boosters effective against severe Omicron in nursing homes

CIDRAP – A study today in Morbidity and Mortality Weekly Report shows that US nursing home residents who received a second mRNA COVID-19 vaccine booster dose 60 days earlier were 26% protected against Omicron infection, 74% against hospitalization or death, and 90% against death alone. A team led by researchers from the Veterans Administration Medical Center in Providence, Rhode […]

Sep 29, 2022

Effectiveness of primary series and booster vaccination against SARS-CoV-2 infection and hospitalisation among adolescents aged 12–17 years in Singapore: a national cohort study

The Lancet – Singapore offered the BNT162b2 vaccine (tozinameran; Pfizer-BioNTech) to adolescents aged 12–17 years in May 18, 2021, and extended booster vaccines to this group in Jan 21, 2022. Literature on the effectiveness of primary series and booster vaccination among adolescents is scarce outside of Europe and North America. We aimed to determine primary […]

Sep 29, 2022

Ebola experimental vaccine trial may begin soon in Uganda

STAT News – A clinical trial of one or perhaps two experimental vaccines designed to protect against the Ebola Sudan virus could soon begin in Uganda, as long as the country agrees to allow the research to take place, an official of the World Health Organization said Wednesday. The trial could get underway within a couple […]

Sep 29, 2022

Study confirms link between COVID-19 vaccination and temporary increase in menstrual cycle length

NIH – A large international study has confirmed the findings of a previous U.S. study that linked COVID-19 vaccination with an average increase in menstrual cycle length of less than one day. The increase was not associated with any change in the number of days of menses (days of bleeding). Funded by the National Institutes of Health, […]

Sep 28, 2022